Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
York Water
YORW
$502M
| $1.56M | ﹤0.01% |
32,564
-11,982
| -27% | -$520K |
|
2502
Oppenheimer Holdings
OPY
$1.14B
| $1.56M | ﹤0.01% |
71,575
+997
| +1% | +$20.2K |
|
2503
Surgery Partners
SGRY
$2.01B
| $1.56M | ﹤0.01% |
134,452
+3,131
| +2% | +$34.3K |
|
2504
Spok Holdings
SPOK
$228M
| $1.54M | ﹤0.01% |
164,966
+54,640
| +50% | +$566K |
|
|
DNR
2505
DELISTED
Denbury Resources, Inc.
DNR
| $1.54M | ﹤0.01% |
5,586,331
+72,137
| +1% | +$21.7K |
|
2506
Melco Resorts & Entertainment
MLCO
$2.22B
| $1.52M | ﹤0.01% |
98,111
+8,760
| +10% | +$136K |
|
2507
Stoke Therapeutics
STOK
$1.8B
| $1.52M | ﹤0.01% |
63,891
-6,512
| -9% | -$155K |
|
|
CBAY
2508
DELISTED
Cymabay Therapeutics
CBAY
| $1.52M | ﹤0.01% |
435,930
+60,665
| +16% | +$175K |
|
2509
Greif Class B
GEF.B
$4.11B
| $1.52M | ﹤0.01% |
36,346
-369
| -1% | -$14.5K |
|
2510
Limoneira
LMNR
$235M
| $1.52M | ﹤0.01% |
104,720
+8,366
| +9% | +$110K |
|
2511
Accuray
ARAY
$32M
| $1.52M | ﹤0.01% |
747,285
-70,096
| -9% | -$146K |
|
2512
Collegium Pharmaceutical
COLL
$1.15B
| $1.5M | ﹤0.01% |
85,955
+4,969
| +6% | +$97.3K |
|
2513
Franklin Covey
FC
$242M
| $1.5M | ﹤0.01% |
70,152
+10,087
| +17% | +$204K |
|
|
RAPT
2514
DELISTED
RAPT Therapeutics
RAPT
| $1.5M | ﹤0.01% |
6,470
+2,766
| +75% | +$428K |
|
|
SCPL
2515
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $1.5M | ﹤0.01% |
101,172
+6,257
| +7% | +$76.8K |
|
|
TCRR
2516
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.5M | ﹤0.01% |
97,649
+16,443
| +20% | +$190K |
|
|
HCCI
2517
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $1.5M | ﹤0.01% |
85,785
+6,118
| +8% | +$103K |
|
2518
KRONOS Worldwide
KRO
$693M
| $1.49M | ﹤0.01% |
143,467
+7,190
| +5% | +$67.4K |
|
2519
Red River Bancshares
RRBI
$662M
| $1.49M | ﹤0.01% |
34,018
+23,542
| +225% | +$919K |
|
2520
Alpha Metallurgical Resources
AMR
$1.74B
| $1.49M | ﹤0.01% |
489,965
+187,139
| +62% | +$672K |
|
2521
SiTime
SITM
$16B
| $1.49M | ﹤0.01% |
31,420
+21,002
| +202% | +$623K |
|
2522
Lifecore Biomedical
LFCR
$166M
| $1.48M | ﹤0.01% |
186,401
+14,257
| +8% | +$147K |
|
2523
Utah Medical Products
UTMD
$225M
| $1.48M | ﹤0.01% |
16,668
+3,417
| +26% | +$307K |
|
2524
Bridgewater Bancshares
BWB
$571M
| $1.47M | ﹤0.01% |
143,467
+9,082
| +7% | +$87.9K |
|
|
FRTA
2525
DELISTED
Forterra, Inc
FRTA
| $1.47M | ﹤0.01% |
131,616
+9,346
| +8% | +$77.1K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.